Type-dependent E6/E7 mRNA expression of single and multiple high-risk human papillomavirus infections in cervical neoplasia.

[1]  E. Andersson,et al.  Type-Specific Human Papillomavirus E6/E7 mRNA Detection by Real-Time PCR Improves Identification of Cervical Neoplasia , 2011, Journal of Clinical Microbiology.

[2]  S. Wacholder,et al.  Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. , 2011, The Journal of infectious diseases.

[3]  T. Wright,et al.  High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study. , 2011, American journal of clinical pathology.

[4]  S. Franceschi,et al.  Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication , 2011, International journal of cancer.

[5]  N. Muñoz,et al.  Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. , 2010, The Lancet. Oncology.

[6]  T. Iftner,et al.  Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence. , 2010, Journal of the National Cancer Institute.

[7]  Shih-hung Huang,et al.  Type‐specific human papillomavirus oncogene messenger RNA levels correlate with the severity of cervical neoplasia , 2010, International journal of cancer.

[8]  A. Lie,et al.  HPV genotype distribution according to severity of cervical neoplasia. , 2010, Gynecologic oncology.

[9]  M. Frisch,et al.  Multiple human papilloma virus types in cervical infections: competition or synergy? , 2010, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[10]  R. DeSalle,et al.  A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. , 2010, Cancer research.

[11]  Martyn Plummer,et al.  Concurrent Infection with Multiple Human Papillomavirus Types: Pooled Analysis of the IARC HPV Prevalence Surveys , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[12]  M. Tommasino,et al.  The biological properties of E6 and E7 oncoproteins from human papillomaviruses , 2010, Virus Genes.

[13]  G. Fadda,et al.  Clinical Performance of Human Papillomavirus E6 and E7 mRNA Testing for High-Grade Lesions of the Cervix , 2009, Journal of Clinical Microbiology.

[14]  K. Münger,et al.  Oncogenic activities of human papillomaviruses. , 2009, Virus research.

[15]  A. Lie,et al.  Performance of Human Papillomavirus DNA and mRNA Testing Strategies for Women with and without Cervical Neoplasia , 2009, Journal of Clinical Microbiology.

[16]  B. Dal Bello,et al.  Clustering patterns of human papillomavirus genotypes in multiple infections. , 2009, Virus research.

[17]  B. Dal Bello,et al.  Multiple human papillomavirus infection and high grade cervical intraepithelial neoplasia among women with cytological diagnosis of atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions. , 2009, Gynecologic oncology.

[18]  K. Straif,et al.  A review of human carcinogens--Part B: biological agents. , 2009, The Lancet. Oncology.

[19]  S. Franceschi,et al.  Members of the human papillomavirus type 18 family (alpha‐7 species) share a common association with adenocarcinoma of the cervix , 2007, International journal of cancer.

[20]  E. Andersson,et al.  Real-time Taqman PCR targeting 14 human papilloma virus types. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[21]  N. Coleman,et al.  Integration of high‐risk human papillomavirus: a key event in cervical carcinogenesis? , 2007, The Journal of pathology.

[22]  S. Franceschi,et al.  Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update , 2007, International journal of cancer.

[23]  H. Skomedal,et al.  PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses. , 2007, Journal of virological methods.

[24]  Zhi-Ming Zheng,et al.  Papillomavirus genome structure, expression, and post-transcriptional regulation. , 2006, Frontiers in bioscience : a journal and virtual library.

[25]  Xavier Castellsagué,et al.  Chapter 1: HPV in the etiology of human cancer. , 2006, Vaccine.

[26]  J. Berkhof,et al.  Prevalence of types 16 and 33 is increased in high‐risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse , 2005, International journal of cancer.

[27]  Leann Myers,et al.  Prevalence and Clustering Patterns of Human Papillomavirus Genotypes in Multiple Infections , 2005, Cancer Epidemiology Biomarkers & Prevention.

[28]  D. Wallwiener,et al.  Detection of high‐risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT‐polymerase chain reaction , 2004, Journal of medical virology.

[29]  G. Boiteau,et al.  J. Virol. Methods , 1996, Journal of Virological Methods.

[30]  M. Ciotti,et al.  Single or multiple HPV types in cervical cancer and associated metastases. , 2006, Oncology reports.